| abstract |
(57) [Summary]nThe present invention provides novel ascomycins having one or more physiologically hydrolysable, acceptable oxycarbonyl moieties or one or more carboxy moieties, wherein such compounds are pharmaceutically acceptable. In particular, it has been found to be useful for treating asthma and dermatitis. Also provided are methods of making the compounds and pharmaceutical compositions comprising the compounds. |